Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Ubrelvy™ (ubrogepant) – New drug approval
December 23, 2019 - The FDA announced the approval of Allergan’s Ubrelvy (ubrogepant), for the acute treatment of migraine with or without aura in adults.
